Is BPC 157 Legal? Understanding Its Status and Implications When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BPC 157: Experimental Peptide Creates Risk for Athletes FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn Patients Using Wellness Peptides Have No Reliable Information About Whether They Are Safe or Effective, ECRI and ISMP Warn